Richard Pzena’s GSK GSK Stock Holding History

Richard Pzena’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	24,507 +5,684	+30%	+$301K	﹤0.01%	132
2026 Q1	$1.04M	Buy	18,823 +5,379	+40%	+$291K	﹤0.01%	140
2025 Q4	$659K	Buy	13,444 +4,727	+54%	+$220K	﹤0.01%	142
2025 Q3	$376K	Buy	8,717 +1,207	+16%	+$47.1K	﹤0.01%	141
2025 Q2	$288K	Buy	+7,510	New	+$287K	﹤0.01%	142

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Richard Pzena's GSK Position: Q2 2026 in Review

Richard Pzena increased its GSK (GSK) stake by 30% in Q2 2026, buying an estimated $301K and bringing the position to 24,507 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #132.

Richard Pzena first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Richard Pzena held 24,507 shares of GSK worth $1.28M as of Q2 2026.
Richard Pzena bought 5,684 GSK shares in Q2 2026, an estimated $301K.
GSK made up ﹤0.01% of Richard Pzena's portfolio in Q2 2026, its #132 holding.
Richard Pzena first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.